Stem Cells and Ageing

Novel therapeutics and routine utilization of autologous stem cell transplantation have prompted considerable changes in persistent survival, in spite of the fact that enhancements have been more great among patients more younger than age 65. Europe is the second biggest contributor as far as income for the development of the worldwide stem cells market. Patients from different nations in Europe and in addition the U.S. also, Canada travel to Germany to get medical treatments at reasonable expenses. Likewise, an increasing number of patients are taking the choice of undergoing stem cell procedures in Germany. 

  • Aging and Rejuvenation
  • Stem Cells and Epigenetics
  • Stem Cell Niche
  • Tissue Engineering
  • Genetically Modified Stem Cell Therapy
  • Stem Cell Apoptosis and Signal Transduction
  • Stem Cell Technologies

Related Conference of Stem Cells and Ageing

Stem Cells and Ageing Conference Speakers